Reduction of the vein graft occlusion rate after coronary artery bypass surgery by treatment with a thromboxane receptor antagonist.

The early occlusion rate of vein grafts after coronary artery bypass surgery was reduced to 3.1% by treatment with a selective thromboxane receptor antagonist. The increased bleeding tendency caused by the substance led to a non-significant increase in blood transfusions.

RCT Entities:   Population Interventions Outcomes